| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |